
Amrutajan Health Care Gears Up for Q3 Reveal on 3rd February; Check Key Expectations Here
Click and Sign Up to Get Live Updates on Q3 Results
Updated: 2 Feb 2026 • 3:06 pm
Posted by:

Amrutajan Health Care’s Q3 results FY26 are scheduled to be announced on 3rd February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.
Amrutajan Health Care Q3 Results 2026 Preview
- Amrutajan Health Care’s revenue is expected to be in the range of ₹122.75 crore, a 11.68% YoY increase.
- Profit After Tax, or PAT, is projected to rise by 63.16% YoY.
- Net profit is ₹19.25 crore, up 63.16% YoY
- EBITDA to rise 81.48%
Amrutajan Health Care Share Performance
- Over the past six months, Amrutajan Health Care’s share price has fallen by 14.81% to ₹573.35.
- Moreover, over the past year, the stock has decreased by 13.53%.
- Despite this weak short-term performance, Amrutajan Health Care’s stock has delivered a financially sound 11.36% return over the past 5 years.
- As of 3rd February 2026, the stock traded at ₹575.45 per share.
Key Factors to Watch for Amrutajan Health Care Q3 Results FY26
- Revenue Growth: How much sales have grown — especially in pain relief, women’s hygiene, and rehydration segments — compared to last year.
- Profitability & Margins: EBITDA and net profit margins to see cost control and operational efficiency in the quarter.
- Seasonality & Demand Trends: Q3 is typically a strong season for products like balms and rehydration solutions — watch if demand remains robust.
- Product Mix & New Launches: Impact of new products or expansion into adjacent categories (like Comfy, Electro+) on overall growth.
- Cash Flow / Balance Sheet Strength: Debt levels, cash generation, and receivables management (e.g., debtor turnover) for financial health signposts.
Final Thoughts
Amrutajan Health Care will announce its Q3 FY26 results on 2nd February 2026. Analysts expect 11.68% YoY revenue growth, a 63.16% rise in PAT, and a 81.48% rise in EBITDA. Amrutanjan Health Care focuses on consumer healthcare products, including pain relief balms, women’s hygiene products, and rehydration solutions, with an emphasis on brand strength, seasonal demand, and margin improvement.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Recent Articles
Capital Small Finance Bank Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Carborundum Universal Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Capri Global Capital Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Digitide Solutions Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Flair Writing Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
GHCL Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Apar Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Apollo Pipes Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Recent Articles

Waterways Leisure Tourism IPO GMP Day 2: Cordelia Cruises GMP at ₹13, Expected Listing ₹821
24 June 2026

Turtlemint Fintech IPO Listing Preview: GMP ₹2, Expected Listing ₹154 — Sell or Hold Analysis
24 June 2026

Anubhav Plast IPO Allotment: Check Status, GMP at ₹0 and Expected Listing at ₹80
24 June 2026

Dhanwel Hybrid Seeds IPO GMP Day 1: Grey Market Premium ₹0, Expected Listing at ₹99
24 June 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Waterways Leisure Tourism IPO GMP Day 2: Cordelia Cruises GMP at ₹13, Expected Listing ₹821
Turtlemint Fintech IPO Listing Preview: GMP ₹2, Expected Listing ₹154 — Sell or Hold Analysis
Anubhav Plast IPO Allotment: Check Status, GMP at ₹0 and Expected Listing at ₹80
Dhanwel Hybrid Seeds IPO GMP Day 1: Grey Market Premium ₹0, Expected Listing at ₹99
Shreedhar Spinners IPO GMP Day 2: Grey Market Premium at ₹0, Expected Listing at Issue Price
Popular this week
Waterways Leisure Tourism IPO GMP Day 2: Cordelia Cruises GMP at ₹13, Expected Listing ₹821
Turtlemint Fintech IPO Listing Preview: GMP ₹2, Expected Listing ₹154 — Sell or Hold Analysis
Anubhav Plast IPO Allotment: Check Status, GMP at ₹0 and Expected Listing at ₹80
Dhanwel Hybrid Seeds IPO GMP Day 1: Grey Market Premium ₹0, Expected Listing at ₹99
Shreedhar Spinners IPO GMP Day 2: Grey Market Premium at ₹0, Expected Listing at Issue Price

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





